6 – 10 of 520
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
(
- Contribution to journal › Article
-
Mark
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden
(
- Contribution to journal › Article
-
Mark
Re: Mark N. Brook, Holly Ní Raghallaigh, Koveela Govindasami, et al. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Eur Urol 2023;83:257-66
(
- Contribution to journal › Letter
-
Mark
Are population level familial risks and germline genetics meeting each other?
(
- Contribution to journal › Scientific review
-
Mark
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
(
- Contribution to journal › Article